Chronic rhinosinusitis
Conditions
Interventions
Group FPND:fluticasone propionate nasal drops
Group Control:Budesonide nasal spray
Sponsors
The First Affiliated Hospital, Sun Yat-sen University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1: between the ages of 18 and 65; 2: The patient was diagnosed with chronic sinusitis and had received endoscopic sinus surgical treatment; 3: Patients with chronic sinusitis who were partially controlled after surgery were evaluated according to EPOS 2020 guidelines; 4: Sign informed consent.
Exclusion criteria
Exclusion criteria: 1: Serious cardiovascular disease, liver and kidney dysfunction, and other vital organ diseases; 2: Have an immune deficiency or are receiving immunosuppressive treatment; 3: Pregnant or lactating women; 4: Allergic to fluticasone propionate or other steroid drugs; 5: Have mental or cognitive disorders, unable to cooperate with research requirements; 6: Recent use of other local or systemic nasal treatment drugs 7: Other conditions considered inappropriate for participation in this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| E-score%;VAS;SNOT-22; | — |
Countries
China
Contacts
Public ContactWendong Liu
The First Affiliated Hospital, Sun Yat-sen University
Outcome results
None listed